Kevin Dunworth,Richard J. Kana,Theodore Sand,Matthew Murphy
申请号：
US15147586
公开号：
US20160250259A1
申请日:
2016.05.05
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention is directed to a therapeutic composition that includes a first cell preparation that includes isolated stromal cells of a first type and a second cell preparation that includes isolated stromal cells of a second type. The first and second cell preparations may include cultured cells. The stromal cells may include adipose stromal cells and bone marrow derived stromal cells. The therapeutic composition may include a blood component that includes one or more of platelet-poor plasma, concentrated platelet-poor plasma, platelet-rich plasma, and whole blood.
